Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any supplement regimen or making changes to your health routine. The information presented here is based on published research but should not replace professional medical guidance.
What Are the Hallmarks of Aging?
In 2013, a landmark paper by López-Otín and colleagues in the journal Cell proposed that biological aging is not a single process but the cumulative result of nine distinct cellular and molecular mechanisms. They called these the “hallmarks of aging” — a framework that has since become the dominant language of aging research worldwide.
The idea was elegant: if we could identify the root causes of aging at the cellular level, we could potentially intervene in each one. A decade on, the framework has been updated, expanded, and refined — but the core concept remains the backbone of longevity science.
In 2023, the same team published a major update in Cell expanding the hallmarks to twelve, adding three newly validated mechanisms. Understanding these hallmarks is the foundation of understanding everything from NMN and senolytics to rapamycin and caloric restriction.
The Original Nine Hallmarks (2013)
The 2013 López-Otín framework divided the nine hallmarks into three categories based on their causal relationship to aging:
| Category | Hallmarks | Role |
|---|---|---|
| Primary causes | Genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis | Initiate cellular damage |
| Antagonistic | Deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence | Protective at low levels; harmful when chronic |
| Integrative | Stem cell exhaustion, altered intercellular communication | Result from accumulated damage; directly cause aging phenotypes |
The 2023 update added three hallmarks to the antagonistic/integrative tiers: disabled macroautophagy, chronic inflammation (inflammaging), and dysbiosis. It also clarified the relationships between existing hallmarks based on a decade of new research.
The 2023 Update: Three New Hallmarks
The expanded 2023 framework (López-Otín et al., Cell) acknowledged that three additional processes had accumulated sufficient evidence to be considered core drivers of aging:
- Disabled macroautophagy — The cellular recycling system that clears damaged proteins and organelles declines with age. This was previously subsumed under proteostasis but is now recognised as a distinct and targetable hallmark.
- Chronic inflammation (inflammaging) — Low-grade, sterile, systemic inflammation that persists with age. It drives cardiovascular disease, neurodegeneration, diabetes, and cancer — essentially every major age-related disease.
- Dysbiosis — Age-related changes in the gut microbiome that reduce microbial diversity, increase gut permeability, and fuel systemic inflammation.
Each Hallmark Explained
1. Genomic Instability
Every cell division and environmental exposure — UV radiation, reactive oxygen species, chemical mutagens — can damage DNA. Our cells have elaborate repair machinery (base excision repair, nucleotide excision repair, double-strand break repair) but this machinery is imperfect and itself declines with age.
The result: accumulated mutations, chromosomal abnormalities, and transcriptional errors that impair cellular function and drive cancer risk. Studies in centenarians suggest that exceptional genome maintenance efficiency may be a key factor in reaching extreme old age.
Intervention targets: Minimising oxidative stress (antioxidants, sleep, exercise), NAD+ restoration (supports PARP DNA repair enzymes), sun protection.
2. Telomere Attrition
Telomeres are the protective caps at the ends of chromosomes — often compared to the plastic tips on shoelaces. Each cell division shortens them. When telomeres become critically short, the cell either enters senescence or dies. Telomere length is one of the most widely studied biomarkers of biological age.
The enzyme telomerase can extend telomeres, but it is largely inactive in adult somatic cells (with important exceptions including stem cells and immune cells). Short telomeres are associated with cardiovascular disease, immune decline, and all-cause mortality.
Key research: A 2012 study by Cawthon et al. showed that individuals in the shortest telomere quartile had a 3-fold higher risk of heart disease death compared to those in the longest quartile. Exercise has consistently been shown to preserve telomere length — one mechanism through which physical activity slows biological aging.
Intervention targets: Regular endurance exercise, stress reduction, sleep quality, omega-3 fatty acids (associated with slower telomere shortening in observational studies).
3. Epigenetic Alterations
The epigenome is the system of chemical modifications — primarily DNA methylation and histone modification — that control which genes are expressed without altering the DNA sequence itself. It is highly responsive to lifestyle, environment, and age.
With aging, the epigenome drifts: methylation patterns become disordered, heterochromatin (which silences repetitive DNA elements) loosens, and gene expression programs that should remain stable in differentiated cells begin to blur. David Sinclair‘s Information Theory of Aging proposes that this epigenetic noise — the loss of the epigenome’s “programme” — is the primary driver of aging.
Biological clocks: Steve Horvath’s epigenetic clock (2013) demonstrated that DNA methylation patterns predict biological age with remarkable accuracy — sometimes better than chronological age at predicting disease and mortality. Subsequent clocks (PhenoAge, GrimAge, DunedinPACE) measure not just age but pace of aging.
Intervention targets: NMN/NR (support sirtuins which regulate histone deacetylation), resveratrol (sirtuin activator), caloric restriction, spermidine (supports histone acetylation patterns).
4. Loss of Proteostasis
Proteostasis — protein homeostasis — refers to the cell’s ability to maintain a healthy, functional protein population. This requires correctly folding new proteins, repairing damaged ones, and degrading those beyond repair. Three main systems maintain proteostasis: molecular chaperones (e.g., heat shock proteins), the ubiquitin-proteasome system, and autophagy.
With age, all three systems decline. The result is the accumulation of misfolded, aggregated proteins that are characteristic of neurodegenerative diseases: amyloid-β and tau in Alzheimer’s, α-synuclein in Parkinson’s, TDP-43 in ALS.
Intervention targets: Autophagy induction via intermittent fasting, exercise, and spermidine; heat shock protein upregulation via sauna; proteasome support.
5. Disabled Macroautophagy
Autophagy (self-eating) is the cell’s primary recycling system. Macroautophagy specifically involves the formation of double-membrane vesicles (autophagosomes) that engulf damaged organelles, protein aggregates, and pathogens, then fuse with lysosomes for degradation and recycling.
Autophagy declines with age due to reduced expression of autophagy genes, impaired lysosomal function, and disruption of the mTOR/AMPK signalling axis. This links directly to proteostasis failure, mitochondrial quality control, and the accumulation of senescent cells.
Key research: Spermidine was identified as a potent autophagy inducer in a 2009 study by Eisenberg et al. in Nature Cell Biology. More recent work (Madeo et al., 2018) showed spermidine extends lifespan in yeast, flies, worms, and mice — largely through autophagy induction. Intermittent fasting triggers autophagy by suppressing mTORC1 signalling via AMPK activation.
Intervention targets: Spermidine supplementation, intermittent fasting, caloric restriction, exercise (Zone 2 cardio activates AMPK), rapamycin (mTOR inhibitor — research use only).
6. Deregulated Nutrient Sensing
Four key nutrient-sensing pathways govern cellular responses to energy availability and influence lifespan:
- IGF-1/insulin signalling: High IGF-1 and chronic insulin elevation promote growth and reproduction but accelerate aging. DAF-16 pathway mutations that reduce IGF-1 signalling dramatically extend lifespan in C. elegans.
- mTOR (mechanistic target of rapamycin): The master growth regulator. mTORC1 promotes protein synthesis and cell growth; when chronically active (as in constant feeding), it suppresses autophagy and accelerates aging. Rapamycin extends lifespan in every organism tested to date, including mice.
- AMPK: The cellular fuel gauge — activated by low energy states (fasting, exercise). AMPK promotes mitochondrial biogenesis, activates autophagy, and suppresses mTOR. Metformin activates AMPK indirectly.
- Sirtuins: NAD+-dependent deacylases that sense the NAD+/NADH ratio (a proxy for cellular energy status). Sirtuin activity declines with age as NAD+ levels fall. They regulate DNA repair, inflammation, mitochondrial function, and fat metabolism.
Intervention targets: Intermittent fasting, caloric restriction, exercise, NMN/NR (raise NAD+ to support sirtuins), metformin (AMPK activator, prescription), berberine (AMPK activator, OTC).
7. Mitochondrial Dysfunction
Mitochondria are the cell’s power generators — and one of the most critical aging hallmarks. With age, mitochondria accumulate DNA mutations (mtDNA is poorly protected compared to nuclear DNA), their membrane potential declines, reactive oxygen species (ROS) production increases, and the balance between mitochondrial fission and fusion shifts unfavourably.
The result: less efficient ATP production, more oxidative damage to cellular components, impaired calcium signalling, and — critically — dysregulation of apoptosis. Muscle weakness, cognitive decline, and cardiovascular deterioration are all partly driven by mitochondrial dysfunction.
Key research: Gomes et al. (2013, Cell) demonstrated that declining NAD+ with age reduces SIRT1 activity, which in turn allows HIF-1α to suppress PGC-1α — the master regulator of mitochondrial biogenesis. Restoring NAD+ via NMN reversed this decline and improved mitochondrial function in aged mice.
Intervention targets: NMN/NR (NAD+ precursors), Zone 2 cardio (drives mitochondrial biogenesis via PGC-1α), urolithin A (triggers mitophagy to clear damaged mitochondria), CoQ10 (electron transport chain support), cold exposure (mitochondrial biogenesis via UCP1).
8. Cellular Senescence
Senescent cells are cells that have permanently withdrawn from the cell cycle — they no longer divide, but they also refuse to die. They accumulate with age and secrete a cocktail of pro-inflammatory cytokines, chemokines, and proteases collectively called the senescence-associated secretory phenotype (SASP).
The SASP drives chronic inflammation, disrupts tissue architecture, impairs stem cell function in neighbouring cells, and can spread senescence to healthy cells through paracrine signalling. Senescent cells accumulate in fat tissue, liver, kidney, brain, and virtually every tissue — acting as a systemic inflammatory burden.
Senolytics vs senomorphics: Senolytics selectively kill senescent cells (dasatinib + quercetin, fisetin). Senomorphics suppress the SASP without killing the cells (rapamycin, spermidine, NAD+ precursors). Both strategies are in human clinical trials.
Key research: Baker et al. (2011, Nature) demonstrated that clearing senescent cells in a progeroid mouse model dramatically improved healthspan. Subsequent work (Baker et al., 2016) showed clearing senescent cells in naturally aged mice extended median lifespan by 25%.
Intervention targets: Fisetin (senolytic, most bioavailable from strawberries), quercetin + dasatinib (clinical trial regimen), exercise (reduces senescent cell burden), caloric restriction.
9. Stem Cell Exhaustion
Stem cells maintain tissue homeostasis throughout life — replacing lost cells in the gut epithelium, skin, blood, and muscle. With age, stem cell pools decline in number, activity, and regenerative capacity. The result: impaired tissue repair, reduced immune function (as haematopoietic stem cells decline), muscle loss, and slowed wound healing.
Stem cell exhaustion is both a result of upstream hallmarks (telomere shortening, epigenetic drift, senescent cell SASP) and a direct driver of aging phenotypes. Young blood plasma experiments — parabiosis studies connecting young and old mice — demonstrated that circulating factors can partially restore aged stem cell function, launching an entire field of investigation into systemic rejuvenation factors.
Intervention targets: Exercise (maintains haematopoietic and muscle stem cell pools), caloric restriction, senolytics (reducing SASP burden may restore stem cell niches), emerging plasma fractionation therapies (research stage).
10. Altered Intercellular Communication
Cells communicate through hormones, cytokines, growth factors, extracellular vesicles, and direct cell-to-cell contact. With aging, these communication networks deteriorate: pro-inflammatory signalling increases (inflammaging), neurohormonal regulation declines (falling growth hormone, testosterone, oestrogen), and the composition of circulating exosomes changes.
Perhaps the most striking example is the SASP — senescent cells essentially broadcast a distress signal throughout the body that accelerates aging in otherwise healthy tissue. This intercellular communication breakdown is why aging is systemic: a dysfunctional liver, adipose tissue, or immune system can accelerate aging in distant organs.
Intervention targets: Senolytics (to reduce SASP), anti-inflammatory dietary patterns (Mediterranean diet), omega-3 fatty acids, exercise (rebalances cytokine profiles).
11. Chronic Inflammation (Inflammaging)
Inflammaging — chronic, low-grade, sterile inflammation — is one of the most consistent features of aging across species and is associated with virtually every major age-related disease: atherosclerosis, type 2 diabetes, Alzheimer’s, Parkinson’s, cancer, and sarcopenia.
Sources include: SASP from senescent cells, mitochondrial DNA leaking into the cytoplasm (activating the cGAS-STING pathway), gut-derived LPS from dysbiosis, and declining immune regulatory function (immunosenescence). Unlike acute inflammation (which is protective and resolves), inflammaging is chronic and self-sustaining.
Elevated CRP, IL-6, TNF-α, and IL-1β are reliable biomarkers of inflammaging and predict disease risk and mortality independently of conventional risk factors.
Intervention targets: Omega-3 fatty acids (EPA/DHA), Mediterranean diet, senolytics, exercise, sleep optimisation, spermidine, fisetin, NMN (via sirtuin-mediated suppression of NF-κB).
12. Dysbiosis
The gut microbiome undergoes significant compositional shifts with age: reduced diversity, decline in beneficial genera (Bifidobacterium, Akkermansia muciniphila, Lactobacillus), increased abundance of pathobionts, and greater gut permeability (“leaky gut”). This allows bacterial components like LPS to translocate into systemic circulation, fuelling inflammaging.
A landmark 2021 study in Nature Aging analysed the gut microbiomes of over 9,000 individuals aged 18–101 and found that healthy centenarians had distinctly high microbial diversity and unique microbial signatures compared to less-healthy controls of the same age.
Intervention targets: Fermented foods (kimchi, kefir, yoghurt, sauerkraut — a 2021 Stanford trial showed they significantly increased microbiome diversity and reduced inflammatory markers), prebiotic fibre, polyphenols (selectively feed beneficial bacteria), spermidine (also produced by gut bacteria and upregulated by polyamine-rich foods).
How the Hallmarks Connect
The hallmarks are not isolated silos — they form a tightly coupled network in which damage in one accelerates damage in others. Here are the key feedback loops that matter for intervention:
The NAD+ Cascade
NAD+ decline (driven by CD38 overexpression, PARP overactivation during DNA repair, and reduced biosynthesis) → reduced sirtuin activity → epigenetic drift + mitochondrial dysfunction + impaired DNA repair → genomic instability + more DNA damage → more PARP activation → further NAD+ decline. A vicious cycle that NMN/NR supplementation aims to break.
The Senescence-Inflammation Loop
Senescent cells release SASP → chronic inflammation (inflammaging) → inflammatory cytokines induce senescence in nearby healthy cells → more senescent cells → more SASP → more inflammation. Senolytics break this loop by eliminating the source.
The Autophagy-Proteostasis-Mitochondria Triangle
Declining autophagy → accumulation of damaged mitochondria (should be cleared by mitophagy) → increased ROS from dysfunctional mitochondria → oxidative damage to proteins → proteostasis failure → more misfolded proteins that require autophagy to clear → autophagy overwhelmed. Autophagy induction (fasting, spermidine, exercise) addresses all three simultaneously.
The mTOR Axis
Chronic mTOR activation (from constant feeding, high IGF-1, excess protein) → suppressed autophagy → suppressed AMPK → impaired mitochondrial biogenesis → impaired NAD+ signalling → accelerated aging across multiple hallmarks. This is why dietary patterns (particularly intermittent fasting and moderate caloric restriction) have such broad anti-aging effects.
Targeting the Hallmarks: What Actually Works
Here is where I want to be direct with you: the hallmarks framework tells us which biological targets matter, but the translation from “mouse study” to “human benefit” is genuinely difficult. Most interventions that extend lifespan in model organisms have not yet been proven to do so in humans. That said, the mechanistic evidence is strong enough that certain strategies warrant serious consideration.
| Intervention | Hallmarks Targeted | Evidence Level | Practical Notes |
|---|---|---|---|
| Exercise (Zone 2 + resistance) | Telomere attrition, mitochondrial dysfunction, stem cell exhaustion, senescence, inflammaging | ★★★★★ Human RCTs | The most broadly validated anti-aging intervention. Non-negotiable. |
| Intermittent fasting / caloric restriction | Nutrient sensing, autophagy, proteostasis, epigenetics, inflammaging | ★★★★☆ Strong mechanistic + some human data | 16:8 minimum; 5:2 for deeper benefits. Circadian-aligned TRE preferable. |
| NMN / NR | NAD+ depletion, mitochondrial dysfunction, epigenetics, DNA repair, senescence (via SASP) | ★★★☆☆ Strong preclinical; early human trials promising | 250–500 mg NMN daily. Take with fat. Morning dosing may be preferable. |
| Spermidine | Autophagy, proteostasis, epigenetics (histone acetylation), inflammaging | ★★★☆☆ Strong preclinical; human observational + RCTs | 1–2 mg/day dietary; 5–10 mg/day via supplement. Wheat germ, natto, mushrooms high in spermidine. |
| Fisetin | Cellular senescence (senolytic), inflammaging, proteostasis | ★★★☆☆ Strong preclinical; Phase 2 human trials ongoing | Pulsed dosing: 100 mg/kg equivalent, 2 consecutive days per month. Bioavailability challenge. |
| Urolithin A | Mitochondrial dysfunction (mitophagy), autophagy, muscle stem cell function | ★★★☆☆ Human RCTs (muscle function) | 500–1000 mg daily. One of few supplements with published human RCT data on mitochondrial function. |
| Rapamycin (mTOR inhibitor) | Nutrient sensing, autophagy, senescence, inflammaging | ★★★★☆ Preclinical + growing physician-led human data | Prescription only. Weekly dosing protocols being explored. Not for general supplementation. |
| Metformin | Nutrient sensing (AMPK), mitochondrial function, inflammation | ★★★☆☆ TAME trial ongoing | Prescription only. 500–1000 mg. Potential interference with exercise adaptations. |
| Mediterranean diet | Inflammaging, dysbiosis, nutrient sensing, proteostasis | ★★★★★ Large human cohort studies + RCTs | The single most evidence-backed dietary pattern for longevity across populations. |
The Research Frontier
The hallmarks framework is not static — it is a living model that evolves as research advances. Here are the most significant active areas:
Epigenetic Reprogramming
The most exciting — and most speculative — area in aging research. Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) can reset the epigenome of aged cells to a younger state. Partial reprogramming — using the factors transiently, not fully — has shown remarkable results in restoring vision in aged mice (Sinclair lab, 2020), reversing kidney and muscle aging in mice, and improving cognitive function.
Altos Labs, with a $3 billion war chest, is the leading commercial entity pursuing this. Human trials are likely still 5–10 years away, but this may represent the most fundamental approach to aging reversal yet conceived.
Senolytics in Human Trials
The Mayo Clinic and others are running Phase 1/2 human trials of dasatinib + quercetin in diabetic kidney disease, Alzheimer’s disease, and frailty. Results to date are cautiously encouraging. Unity Biotechnology is pursuing intra-articular senolytic injections for osteoarthritis.
The TAME Trial
The Targeting Aging with Metformin (TAME) trial is the first FDA-approved clinical trial with “aging” as its primary endpoint — a landmark regulatory and scientific milestone. Results will inform whether metformin meaningfully delays the onset of multiple age-related diseases simultaneously.
Longevity Escape Velocity
The concept, popularised by Aubrey de Grey, holds that as rejuvenation therapies compound and improve, it may become possible to extend life faster than it ages — effectively making biological aging optional for those who reach that threshold while still alive. Most mainstream geroscientists consider this premature optimism, but the rate of progress in the field is genuinely accelerating.
Frequently Asked Questions
How many hallmarks of aging are there?
The most current framework (López-Otín et al., Cell, 2023) recognises twelve hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation (inflammaging), and dysbiosis. The original 2013 paper described nine hallmarks; the 2023 update added three.
Which hallmark of aging is most important?
This is debated among researchers. David Sinclair argues epigenetic alterations (loss of epigenetic information) is the primary driver — essentially a master cause from which others follow. Others prioritise cellular senescence and inflammaging as the most tractable therapeutic targets. The consensus view is that no single hallmark is “most important” — they form an interconnected network, and targeting multiple hallmarks simultaneously is more effective than targeting any single one.
Can the hallmarks of aging be reversed?
In animal models, yes — several hallmarks have been partially reversed, including epigenetic aging (via partial reprogramming), mitochondrial function (via NAD+ restoration), and senescent cell burden (via senolytics). In humans, certain interventions — exercise, caloric restriction, and senolytics — have been shown to reduce biological age markers and senescent cell burden. Full reversal in humans remains aspirational, but measurable improvements in multiple hallmarks are achievable with current interventions.
Does NMN target the hallmarks of aging?
Yes. NMN (nicotinamide mononucleotide) raises NAD+ levels, which supports sirtuin function — impacting at least five hallmarks directly: epigenetic alterations (sirtuins regulate histone deacetylation), mitochondrial dysfunction (SIRT1/3 support mitochondrial biogenesis and function), DNA repair (PARP enzymes require NAD+), cellular senescence (NAD+ depletion contributes to SASP), and deregulated nutrient sensing (sirtuins are the key effectors of NAD+-dependent longevity signalling).
What is the difference between a senolytic and a senomorphic?
Senolytics selectively kill senescent cells — compounds in this class include dasatinib (a cancer drug), quercetin, and fisetin. Senomorphics (also called senostatics) suppress the SASP — the inflammatory secretions of senescent cells — without killing the cells themselves. Rapamycin and spermidine have senomorphic properties. Both strategies reduce the downstream harm caused by senescent cell accumulation, but via different mechanisms.
What is inflammaging?
Inflammaging is the term for the chronic, low-grade, sterile inflammatory state that develops with aging. Unlike acute inflammation (which is protective and resolves), inflammaging is persistent and systemic. It is driven by senescent cell SASP, gut dysbiosis, mitochondrial damage, and immune dysfunction. Elevated CRP, IL-6, and TNF-α are its biomarkers. It is a major driver of virtually every age-related disease — cardiovascular disease, Alzheimer’s, type 2 diabetes, sarcopenia — and is now recognised as a formal hallmark of aging.
Citations
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217. PMID: 23746838
- López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. PMID: 36599349
- Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479(7372):232-236. PMID: 22048312
- Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature. 2016;530(7589):184-189. PMID: 26840489
- Gomes AP, Price NL, Ling AJ, et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624-1638. PMID: 24360282
- Eisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. Nature Cell Biology. 2009;11(11):1305-1314. PMID: 19801973
- Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science. 2018;359(6374):eaan2788. PMID: 29371440
- Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14(10):R115. PMID: 24138928
- Wilmanski T, Diener C, Rappaport N, et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nature Metabolism. 2021;3(2):274-286. PMID: 33619379
- Sonnenburg JL, Dahl WJ, Dahl WJ, Sonnenburg JL, Gardner CD. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.e14. PMID: 34256014